Your browser doesn't support javascript.
loading
Unconventional treatment of inoperable biliary IPMN with an oesophageal stent in the common bile duct: case report.
Siiki, Antti; Antila, Anne; Vaalavuo, Yrjö; Ronkainen, Johanna; Rinta-Kiikka, Irina; Laukkarinen, Johanna.
Afiliación
  • Siiki A; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Teiskontie 35, PO BOX 2000, 33521 Tampere, Finland.
  • Antila A; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland.
  • Vaalavuo Y; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland.
  • Ronkainen J; Department of Radiology, Imaging Centre and Pharmacy, Tampere University Hospital, Tampere, Finland.
  • Rinta-Kiikka I; Department of Radiology, Imaging Centre and Pharmacy, Tampere University Hospital, Tampere, Finland.
  • Laukkarinen J; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland.
Ther Adv Gastrointest Endosc ; 16: 26317745231183311, 2023.
Article en En | MEDLINE | ID: mdl-37533690
Biliary intraductal papillary mucinous neoplasm (IPMN) is a rare biliary neoplasia preferably treated with oncologic resection. Endoscopic radio frequency (RF) ablation may be used as a palliative measure. We present a rare case, where heavy co-morbidities prevented surgery. Continuous mucus production caused recurrent episodes of severe cholangitis. Several ERCPs (endoscopic retrograde cholangio pancretography) were necessary due to recurrent biliary obstruction. RF ablation was not effective in the dilated common bile duct without a stricture. Standard biliary stents failed due to either migration or occlusion. When other options failed, an exceptional decision was made: a covered large diameter oesophageal stent was inserted in ERCP into the bile duct to secure bile flow and stop mucus production. Digital cholangioscopy was crucial adjunct to standard ERCP in endoscopic management. The palliative treatment method was successful: there were no stent-related adverse events or readmissions for cholangitis. The follow-up in the palliative care lasted until patient's last 10 months of lifetime.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Gastrointest Endosc Año: 2023 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Gastrointest Endosc Año: 2023 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Estados Unidos